Literature DB >> 7595618

A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis.

S Abrahams1, P N Leigh, J J Kew, L H Goldstein, C M Lloyd, D J Brooks.   

Abstract

Positron emission tomography (PET) was used to investigate the location of cerebral cortical and subcortical abnormalities in non-demented patients with amyotrophic lateral sclerosis (ALS). Involvement of the frontal lobes was investigated with a task of executive frontal lobe function (verbal fluency/word generation), using a PET activation paradigm. Two groups of ALS patients defined by the presence or absence of cognitive impairment were tested. ALS patients who had cognitive impairments showed a region of cortical and subcortical dysfunction which extended across a wide area of the frontal lobes, and included the insular cortex and thalamic nuclear complex. These findings support the notion that extra-motor involvement is relatively common in ALS and broadens concepts of selective vulnerability in ALS.

Entities:  

Mesh:

Year:  1995        PMID: 7595618     DOI: 10.1016/0022-510x(95)00060-f

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives.

Authors:  Marta Pinto-Grau; Orla Hardiman; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-04-28       Impact factor: 7.444

2.  Neural correlates of cognitive decline in ALS: an fNIRS study of the prefrontal cortex.

Authors:  Mili S Kuruvilla; Jordan R Green; Hasan Ayaz; Daniel L Murman
Journal:  Cogn Neurosci       Date:  2013       Impact factor: 3.065

3.  Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset.

Authors:  Angelina Cistaro; Maria Consuelo Valentini; Adriano Chiò; Flavio Nobili; Andrea Calvo; Cristina Moglia; Anna Montuschi; Silvia Morbelli; Dario Salmaso; Piercarlo Fania; Giovanna Carrara; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-17       Impact factor: 9.236

4.  EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.

Authors:  M Filippi; F Agosta; S Abrahams; F Fazekas; J Grosskreutz; S Kalra; J Kassubek; V Silani; M R Turner; J C Masdeu
Journal:  Eur J Neurol       Date:  2010-02-02       Impact factor: 6.089

5.  Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients.

Authors:  Herbert Schreiber; Tanja Gaigalat; Ursula Wiedemuth-Catrinescu; Michael Graf; Ingo Uttner; Rainer Muche; Albert Christian Ludolph
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

6.  Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS.

Authors:  Colin Quinn; Lauren Elman; Leo McCluskey; Katelin Hoskins; Chafic Karam; John H Woo; Harish Poptani; Sumei Wang; Sanjeev Chawla; Scott E Kasner; Murray Grossman
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 7.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 8.  The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.

Authors:  Tim Van Langenhove; Julie van der Zee; Christine Van Broeckhoven
Journal:  Ann Med       Date:  2012-03-16       Impact factor: 4.709

Review 9.  Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research.

Authors:  Francesca Trojsi; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  Neural Plast       Date:  2012-06-10       Impact factor: 3.599

10.  Working memory in ALS patients: preserved performance but marked changes in underlying neuronal networks.

Authors:  Tino Zaehle; Andreas Becke; Nicole Naue; Judith Machts; Susanne Abdulla; Susanne Petri; Katja Kollewe; Reinhard Dengler; Hans-Jochen Heinze; Stefan Vielhaber; Notger G Müller
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.